index - CRCL-Inflammasome et cancer

Julien Nadjar, Sylvain Monnier, Estelle Bastien, Anne-Laure Huber, Christiane Oddou, et al.. Optogenetically controlled inflammasome activation demonstrates two phases of cell swelling during pyroptosis. Science Signaling, 2024, 17 (833), pp.eabn8003. ⟨10.1126/scisignal.abn8003⟩. ⟨hal-04567594⟩
Mélanie Bodnar-Wachtel, Anne-Laure Huber, Julie Gorry, Sabine Hacot, Delphine Burlet, et al.. Inflammasome-independent NLRP3 function enforces ATM activity in response to genotoxic stress. Life Science Alliance, 2023, 6 (4), pp.e202201494. ⟨10.26508/lsa.202201494⟩. ⟨hal-04052301⟩
Caroline Moyret-Lalle, Mélanie K. Prodhomme, Delphine Burlet, Ayaka Kashiwagi, Virginie Petrilli, et al.. Role of EMT in the DNA damage response, double-strand break repair pathway choice and its implications in cancer treatment. Cancer Science, 2022, 113 (7), pp.2214-2223. ⟨10.1111/cas.15389⟩. ⟨hal-03775767⟩
Tingting Niu, Charlotte de Rosny, Séverine Chautard, Amaury Rey, Danish Patoli, et al.. NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly. Nature Communications, 2021, 12 (1), pp.Article number: 5862. ⟨10.1038/s41467-021-26142-w⟩. ⟨hal-03401509⟩
Aneline Dolet, Rita Ammanouil, Virginie Petrilli, Cédric Richard, Piero Tortoli, et al.. In Vitro and In Vivo Multispectral Photoacoustic Imaging for the Evaluation of Chromophore Concentration. Sensors, 2021, 21 (10), pp.3366. ⟨10.3390/s21103366⟩. ⟨hal-03352856⟩
Mélanie K Prodhomme, Roxane M Pommier, Camille Franchet, Frédérique Fauvet, Valérie Bergoglio, et al.. EMT Transcription Factor ZEB1 Represses the Mutagenic POLθ-Mediated End-Joining Pathway in Breast Cancers. Cancer Research, 2021, 81 (6), pp.1595 - 1606. ⟨10.1158/0008-5472.can-20-2626⟩. ⟨hal-03407927⟩

Derniers manuscrits de l'équipe

Chiffres clés